Tag: Ivosidenib
FDA approves Agios’ Tibsovo for acute myeloid leukemia treatment
Tibsovo (ivosidenib) developed by Agios Pharmaceuticals has been approved by the US Food and Drug Administration (FDA) for acute myeloid leukemia treatment in patients with ... Read More
Ivosidenib FDA approval : Agios blood cancer drug approved for AML
Ivosidenib FDA approval : The US Food and Drug Administration (FDA) has approved Agios Pharmaceuticals’ blood cancer drug TIBSOVO (ivosidenib) for the treatment of acute ... Read More